MADISON, WI - Gentel® Biosciences, a protein microarray life sciences company, announces it has obtained an exclusive license to novel technology for manufacturing highly-reproducible nitrocellulose protein microarray slides.
The technology, developed by Agnitio Science and Technology of Hsinchu, Taiwan, covers the use of ultrasonic coating to produce nitrocellulose films. “Ultrasonic coating produces nitrocellulose films with a consistency unattainable using traditional coating processes like casting,” stated Dr. Bryce Nelson, Gentel’s VP of Research and Development. “Additionally, the technology is extremely flexible and can be used to fabricate optically clear or porous white nitrocellulose films.”
Gentel plans to incorporate ultrasonic coating technology into its manufacturing process for standard microarray slides as well as for its recently developed 96-well microarray platform, APiX 96™.
“The technology is highly scalable and will enable us to manufacture the number and type of protein microarray slides required for protein biomarker discovery, validation, and diagnostics,” said Alex Vodenlich, Gentel's President and CEO. “The acquisition of this intellectual property further extends Gentel’s position as the market leading protein microarray company.”
The ultrasonic coating technology is covered by a suite of issued and pending US and international patents.
ABOUT AGNITIO SCIENCE AND TECHNOLOGY
Agnitio Science & Technology is one of the leading microfluidics technology and information infrastructure providers to the global healthcare and life science industry. Visit www.agnitiost.com for more information.
